Hot Topics | Published:

Unique treatment potential of cannabidiol for the prevention of relapse to drug use

Neuropsychopharmacologyvolume 44page229 (2019) | Download Citation

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Additional information

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  1. 1.

    Campos AC, Moreira FA, Gomes FV, Del Bel EA, Guimaraes FS. Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders. Philos Trans R Soc Lond B Biol Sci. 2012;367:3364–78.

  2. 2.

    Prud’homme M, Cata R, Jutras-Aswad D. Cannabidiol as an intervention for addictive behaviors: a systematic review of the evidence. Subst Abus. 2015;9:33–8.

  3. 3.

    Ren YH, Whittard J, Higuera-Matas A, Morris CV, Hurd YL. Cannabidiol, a nonpsychotropic component of cannabis, inhibits cue-induced heroin seeking and normalizes discrete mesolimbic neuronal disturbances. J Neurosci. 2009;29:14764–9.

  4. 4.

    Campos AC, Fogaca MV, Sonego AB, Guimaraes FS. Cannabidiol, neuroprotection and neuropsychiatric disorders. Pharmacol Res. 2016;112:119–27.

  5. 5.

    Gonzalez-Cuevas G, Martin-Fardon R, Kerr TM, Stouffer DG, Parsons LH, Hammell DC, et al. Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle. Neuropsychopharmacology. 2018;43:2036–45.

  6. 6.

    Hurd YL, Yoon M, Manini AF, Hernandez S, Olmedo R, Ostman M, et al. Early phase in the development of cannabidiol as a treatment for addiction: opioid relapse takes initial center stage. Neurotherapeutics. 2015;12:807–15.

Download references

Acknowledgements

This is publication number 29746 from the Scripps Research Institute. This research was supported by NIH Grants AA022082 (FW), AA021549 (FW), and DA039821 (FW).

Author information

Affiliations

  1. Department of Neuroscience, The Scripps Research Institute, 10550 North Torrey Pines Road (SP30-2120), La Jolla, CA, 92037, USA

    • Friedbert Weiss
    •  & Gustavo Gonzalez-Cuevas
  2. Department of Psychology, European University of Madrid School of Biomedical Sciences, 28670, Madrid, Spain

    • Gustavo Gonzalez-Cuevas

Authors

  1. Search for Friedbert Weiss in:

  2. Search for Gustavo Gonzalez-Cuevas in:

Competing interests

The authors declare no competing interests.

Corresponding author

Correspondence to Friedbert Weiss.

About this article

Publication history

Published

Issue Date

DOI

https://doi.org/10.1038/s41386-018-0218-2